Traditional Chinese medicine for cancer-related fatigue in patients with breast cancer: a randomized, double-blinded, placebo-controlled trial

Beijing Municipal Science and Technology Commission (China)0 个研究点目标入组 118 人开始时间: 2013年8月14日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Women patients having definite pathologic diagnosis of breast cancer in outpatient
•2. Patients who had chemotherapy and /or radiotherapy at least 1 month and mastectomy within 5 years
•3. Stage I to III breast cancer with no evidence of recurrence and metastasis
•4. Eastern Cooperative Oncology Group (ECOG) performance status 0-2
•5. Traditional Chinese Medicine (TCM) syndrome is differentiated as liver depression and spleen deficiency
•6. Anticipated survival time more than six months
•7. Patients having no plan to receive chemoradiotherapy during the study
•8. patients who are suffering from at least moderate fatigue by Revised Piper Fatigue Scale-Chinese Version(RPFS-CV)
•9. All patients who have provided signed informed consent before enrollment

•1. Patients with serious diseases of heart, liver and kidney, immune and hematopoietic system
•2. Children, women who are pregnant
•3. Active treatment for anemia with erythropoietin or blood transfusions
•4. Patients using steroids to cure cancer-related fatigue
•5. Patients having a diagnosis of depression, mental disease and cognitive impairment
•6. Patients allergic to Chinese herbal compound

发起方

Beijing Municipal Science and Technology Commission (China)